Sponsor or institution
Clinical trials and research at Myosin Therapeutics INC.
As of November 12, 2026, Find a Trial lists 1 clinical trial run by Myosin Therapeutics INC. that is recruiting, in United States. By phase: Phase 1/2 (1). There are also 5 NIH-funded research projects at this institution, with $8.1 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 1Clinical trials
- 5NIH research projects
- 1Country
All recruiting trials (1)
-
MT-125 with radiotherapy for newly diagnosed glioblastoma
This trial tests whether adding the experimental drug MT-125 to standard radiotherapy helps people with newly diagnosed IDH wild-type, MGMT-unmethylated glioblastoma.
NIH-funded research (5)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
MT-125: a brain-penetrant treatment to slow glioblastoma spread and growth
A new drug, MT-125, taken by people with recurrent glioblastoma, targets two motor proteins to slow cancer spread and growth inside the brain.
-
MT-125 treatment for recurrent high-grade brain tumors
Adults with recurrent high-grade gliomas will receive the brain-penetrant drug MT-125 to find safe doses and check whether it can slow tumor invasion and growth.
-
Testing a new drug to help reduce methamphetamine use
This study is testing a new treatment called MT-110 to see if it can help people with methamphetamine use disorder stay off the drug by reducing cravings and the urge to use again.
-
New treatment for aggressive brain cancer glioblastoma
This study is testing a new treatment called MT-125 for glioblastoma, a tough type of brain cancer, to see if it can help stop the cancer from growing and spreading, with the hope of improving survival for patients.
-
Developing a new medication to help prevent relapse in methamphetamine users
This study is testing a new medication called MT-110 to help people with methamphetamine use disorder stay off the drug and avoid relapse, since there aren't any approved treatments available right now.
Quick answers
How many clinical trials run by Myosin Therapeutics INC. are recruiting right now?
1, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.